Screener
Cytek Biosciences, Inc. CTKB Total Current Assets
Total Current Assets at other companies
Other financials
Where this comes from
Reported directly by Cytek Biosciences, Inc. in its filing.
Tagged under the XBRL concept us-gaap:AssetsCurrent.
The source filing: Cytek Biosciences, Inc.’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 5:06 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001628280-26-053496
| (In thousands, except share and per share data) | June 30,2026 | December 31,2025 |
|---|---|---|
| Trade accounts receivable, net | 49,698 | 62,509 |
| Inventories | 52,251 | 48,428 |
| Prepaid expenses and other current assets | 13,978 | 19,530 |
| Total current assets | 377,931 | 391,996 |
| Property and equipment, net | 20,801 | 18,009 |
| Operating lease right-of-use assets | 10,962 | 11,315 |
| Goodwill | 16,690 | 16,697 |
| Intangible assets, net | 14,865 | 16,821 |
Item 1. Consolidated Financial Statements (Unaudited)
FAQ
- What is Cytek Biosciences, Inc.'s total current assets?
- Cytek Biosciences, Inc. (CTKB) reported total current assets of $377.93M in Q2 2026.
- How has Cytek Biosciences, Inc.'s total current assets changed year-over-year?
- Cytek Biosciences, Inc.'s total current assets decreased by 1.3% year-over-year, from $382.83M to $377.93M.
- What is the long-term trend for Cytek Biosciences, Inc.'s total current assets?
- Over 5 years (2020 to 2025), Cytek Biosciences, Inc.'s total current assets has grown at a 13.4% compound annual growth rate (CAGR), from $208.62M to $392M.
- What does total current assets mean?
- The sum of all assets expected to be converted to cash or consumed within one year — cash, receivables, inventory, and prepaid expenses.
Ask your AI about Cytek Biosciences, Inc.'s total current assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude